“Gender affirmation surgeries: progress & pitfalls”
Presented by: Thomas Satterwhite, MD
Please join us to hear this Stanford alumnus and plastic surgeon discuss his experiences providing world-leading gender affirmation surgeries for transgender men and women.
Vice Admiral David H. Buss, U.S. Navy (Ret.), will present “Leadership and Talent Management Lessons from the Navy.”
Dr. Andrea Pusic, the recently appointed Chief of Plastic Surgery at the Brigham and Women’s Hospital in Boston, MA, will present “Patient-reported Outcomes in Surgery: Improving Clinical Care and Quality.” Dr. Pusic specializes in breast reconstructive surgery.
Dr. Catherine Curtin, an associate professor in the Division of Plastic and Reconstructive Surgery, will speak about peripheral nerve injury. 
The 22nd Annual Thomas J. Fogarty, MD Lecture: Focus on Innovation
Friday, October 30, 2020 | 4pm
LKSC – Berg Hall | Stanford University
Featuring Julio C. Palmaz, MD, radiologist, honorary Ashbel Smith Professor at the University of Texas Health Science Center, inventor, entrepreneur, and vintner.
The Fogarty lectureship was established to bring together a diverse community in Silicon Valley focusing on leaders in discovery, invention, innovation, and entrepreneurship. This event is sponsored by Stanford Byers Center for Biodesign, Fogarty Institute for Innovation and Stanford Department of Surgery. Watch this space for more information.
Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer. The date of the event is Friday September 30, 2022 at 4pm. It will be a hybrid event.
Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.
Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.
Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.
Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.
Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.